Raymond James Downgrades Prudential Financial to Market Perform
Raymond James analyst Wilma Burdis downgrades Prudential Financial (NYSE:PRU) from Strong Buy to Market Perform.
Citigroup Downgrades Medtronic to Neutral, Lowers Price Target to $85
Citigroup analyst Joanne Wuensch downgrades Medtronic (NYSE:MDT) from Buy to Neutral and lowers the price target from $108 to $85.
JP Morgan Downgrades Noah Holdings to Neutral, Lowers Price Target to $15
JP Morgan analyst Katherine Lei downgrades Noah Holdings (NYSE:NOAH) from Overweight to Neutral and lowers the price target from $24 to $15.
Argus Research Downgrades Vornado Realty to Hold
Argus Research analyst Angus Kelleher-Ferguson downgrades Vornado Realty (NYSE:VNO) from Buy to Hold.
JP Morgan Downgrades M.D.C. Holdings to Underweight, Raises Price Target to $28
JP Morgan analyst Michael Rehaut downgrades M.D.C. Holdings (NYSE:MDC) from Neutral to Underweight and raises the price target from $27 to $28.
Cowen & Co. Downgrades Macrogenics to Market Perform
Cowen & Co. analyst Boris Peaker downgrades Macrogenics (NASDAQ:MGNX) from Outperform to Market Perform.
Baird Downgrades Airbnb to Neutral, Lowers Price Target to $100
Baird analyst Colin Sebastian downgrades Airbnb (NASDAQ:ABNB) from Outperform to Neutral and lowers the price target from $120 to $100.
Baird Downgrades Vroom to Neutral, Lowers Price Target to $2
Baird analyst Colin Sebastian downgrades Vroom (NASDAQ:VRM) from Outperform to Neutral and lowers the price target from $3 to $2.
Wells Fargo Downgrades Expeditors International to Underweight, Announces $95 Price Target
Wells Fargo analyst Allison Poliniak downgrades Expeditors International (NASDAQ:EXPD) from Equal-Weight to Underweight and announces $95 price target.
HC Wainwright & Co. Downgrades Imago BioSciences to Neutral, Raises Price Target to $36
HC Wainwright & Co. analyst Mitchell Kapoor downgrades Imago BioSciences (NASDAQ:IMGO) from Buy to Neutral and raises the price target from $35 to $36.